george jacob

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, announced completion of treatment in an 80 patient multi-center open label, randomized, parallel group Phase II study in India to determine the safety and efficacy of add-on intranasal insulin spray (Nasulin®) in patients with type 2 diabetes mellitus on oral anti-diabetic therapy. The clinical study report is expected to be completed later this month, but preliminary clinical results are being released today.
for more info, visit:
Bentley Pharmaceuticals Announces Completion Of Treatment In Phase II India Clinical Study In Type 2 Diabetes And Preliminary Clinical Results

Terrie

Welcome to the Forum George.

Thanks Very much for the information on these 2 possible treatments.
As usual they both have pros and cons. I had heard of a nasal spray
for treating Diabetes before but there it ended. I wonder if it is the
same company.

The Nasulin would be Good if it caused no damage to the tissues and
for People with needle phobias, etc. The thought of a diabetes product
bringing down glucose faster than the fast acting Insulins that we have
now is both pleasing but could certainly be problematic. Double edged
sword if someone is distracted during the process. It's perplexing why the blood sugar levels would rise after 2 or 3 mths.(if I understand it correctly).
I hope that they figure that one out.

As far as the vaccine, that is also an interesting concept.

As much as we would prefer a cure, it's nice to know that some
companies are still trying to create treatments and products that
might make Diabetes easier to live with.

Thanks again.

george jacob

thanks for the appreciation, i m always trying to send new info about diabetes on this forum, hope it will be useful to people.